Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype
Noriyoshi Kurihara, … , Dirk Anderson, G. David Roodman
Noriyoshi Kurihara, … , Dirk Anderson, G. David Roodman
Published March 1, 2000
Citation Information: J Clin Invest. 2000;105(5):607-614. https://doi.org/10.1172/JCI8489.
View: Text | PDF
Article Article has an altmetric score of 3

Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype

  • Text
  • PDF
Abstract

Osteoclasts (OCLs) in Paget’s disease are markedly increased in number and size, have increased numbers of nuclei per multinucleated cell, and demonstrate increased resorption capacity and increased sensitivity to 1,25-(OH)2D3, the active form of vitamin D. These cells also contain nuclear inclusions, reminiscent of those seen in paramyxovirus-infected cells, which cross-react with antibodies to measles virus nucleocapsid (MVNP) antigen. To elucidate the role of MV in the abnormal OCL phenotype of Paget’s disease, we transduced normal OCL precursors with retroviral vectors expressing MVNP and the MV matrix (MVM) genes. The transduced cells were then cultured with 1,25-(OH)2D3 for14 or 21 days to induce formation of OCL-like multinucleated cells. The MVNP-transduced cells formed increased numbers of multinucleated cells, which contained many more nuclei and had increased resorption capacity compared with multinucleated cells derived from empty vector–transduced (EV-transduced) and MVM-transduced or normal bone marrow cells. Furthermore, MVNP-transduced cells showed increased sensitivity to 1,25-(OH)2D3, and formed OCLs at concentrations of 1,25-(OH)2D3 that were 1 log lower than that required for normal, EV-transduced, or MVM-transduced cells. These results demonstrate that expression of the MVNP gene in normal OCL precursors stimulates OCL formation and induces OCLs that express a phenotype similar to that of pagetic OCLs. These results support a potential pathophysiologic role for MV infection in the abnormal OCL activity and morphology that are characteristic of pagetic OCLs.

Authors

Noriyoshi Kurihara, Sakamuri V. Reddy, Cheikh Menaa, Dirk Anderson, G. David Roodman

×

Total citations by year

Year: 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1997 1991 1988 1980 Total
Citations: 1 1 1 1 5 1 4 5 2 5 8 4 4 4 9 8 3 9 2 12 4 3 3 5 1 1 1 1 108
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (108)

Title and authors Publication Year
The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease
Fu J, Li S, Ma H, Yang J, Pagnotti GM, Brown LM, Weiss SJ, Mapara MY, Lentzsch S
Nature Communications 2023
Update on the pathogenesis and genetics of Paget’s disease of bone
Gennari L, Rendina D, Merlotti D, Cavati G, Mingiano C, Cosso R, Materozzi M, Pirrotta F, Abate V, Calabrese M, Falchetti A
Frontiers in Cell and Developmental Biology 2022
Effects of Bisphenol A and Its Alternatives, Bisphenol F and Tetramethyl Bisphenol F on Osteoclast Differentiation
HM Kim, SM Lee, J Choi, NK Soung, JD Heo
Molecules (Basel, Switzerland) 2021
A review on osteoclast diseases and osteoclastogenesis inhibitors recently developed from natural resources
X Wang, K Yamauchi, T Mitsunaga
Fitoterapia 2020
Paget’s Disease of Bone
L Gennari, D Rendina, A Falchetti, D Merlotti
Calcified Tissue International 2019
The osteoclast, a target cell for microorganisms
B Raynaud-Messina, C Verollet, I Maridonneau-Parini
Bone 2019
Osteoimmunology: evolving concepts in bone–immune interactions in health and disease
M Tsukasaki, H Takayanagi
Nature Reviews Immunology 2019
Fusion and hemagglutinin proteins of canine distemper virus promote osteoclast formation through NF-κB dependent and independent mechanisms
W Wang, W Feng, D Li, S Liu, Y Gao, Z Zhao, Q Fu, L Yan, W Zheng, M Li, X Zheng
Experimental Cell Research 2019
Molecular Diagnosis of Fibro-osseous Lesions of the Oral and Maxillofacial Region: A Tale from Africa
OO Soyele, AH Adedapo, HA Adeola
2019
Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy
L Gennari, D Rendina, T Picchioni, S Bianciardi, M Materozzi, R Nuti, D Merlotti
Expert Opinion on Orphan Drugs 2018
NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone
Y Sambandam, K Sundaram, T Saigusa, S Balasubramanian, SV Reddy
Bone 2017
Measles virus nucleocapsid protein modulates the Signal Regulatory Protein-β1 (SIRPβ1) to enhance osteoclast differentiation in Paget's disease of bone
K Sundaram, Y Sambandam, S Shanmugarajan, DS Rao, SV Reddy
Bone Reports 2017
Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review
H Bi, X Chen, S Gao, X Yu, J Xiao, B Zhang, X Liu, M Dai
Frontiers in Medicine 2017
Orthopedic Nuclear Medicine
AH Elgazzar
Orthopedic Nuclear Medicine 2017
Measles Virus Nucleocapsid Protein Increases Osteoblast Differentiation in Paget's Disease
Jumpei Teramachi, Yuki Nagata, Khalid Mohammad, Yuji Inagaki, Yasuhisa Ohata, Theresa A. Guise, Laetitia Michou, Jacques Brown, Jolene J. Windle, Noriyoshi Kurihara, G. David Roodman
Journal of Clinical Investigation 2016
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee
Endocrinology: Adult and Pediatric 2016
Measles virus nucleocapsid protein modulates the Signal Regulatory Protein-β1 (SIRPβ1) to enhance osteoclast differentiation in Paget's disease of bone
K Sundaram, Y Sambandam, S Shanmugarajan, DS Rao, SV Reddy
Bone Reports 2016
Advances in Pathobiology and Management of Paget's Disease of Bone
DL Galson, Q Sun, GD Roodman
Advances in Pathobiology and Management of Paget's Disease of Bone 2016
Pseudotumors of bone and bone lesions mimicking tumours
MJ Klein, JS Khurana
Diagnostic Histopathology 2016
Genetics of Paget’s disease of bone
OM Albagha
BoneKEy Reports 2015
Diagnosis and Management of Hip Disease
RK Aaron
2015
Pathobiology of Paget's Disease of Bone
DL Galson, GD Roodman
Journal of Bone Metabolism 2014
Increased IL-6 Expression in Osteoclasts Is Necessary But Not Sufficient for the Development of Paget's Disease of Bone: IL-6 IS REQUIRED FOR FORMATION OF PAGET'S DISEASE
J Teramachi, H Zhou, MA Subler, Y Kitagawa, DL Galson, DW Dempster, JJ Windle, N Kurihara, GD Roodman
Journal of Bone and Mineral Research 2014
An Insight in to Paget's Disease of Bone
R Sabharwal, S Gupta, S Sepolia, R Panigrahi, S Mohanty, SK Subudhi, M Kumar
Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2014
Paget’s disease of bone: epidemiology, pathogenesis and pharmacotherapy
L Gennari, D Merlotti, D Rendina, F Gianfrancesco, T Esposito, R Nuti
Expert Opinion on Orphan Drugs 2014
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes
2014
Critical Role of AKT Protein in Myeloma-induced Osteoclast Formation and Osteolysis
H Cao, K Zhu, L Qiu, S Li, H Niu, M Hao, S Yang, Z Zhao, Y Lai, JL Anderson, J Fan, HJ Im, D Chen, GD Roodman, G Xiao
The Journal of biological chemistry 2013
TBK1 Mediates Critical Effects of Measles Virus Nucleocapsid Protein (MVNP) on Pagetic Osteoclast Formation: TBK1 MEDIATES EFFECTS OF MVNP ON OSTEOCLASTS
Q Sun, B Sammut, FM Wang, N Kurihara, JJ Windle, GD Roodman, DL Galson
Journal of Bone and Mineral Research 2013
Role of ATF7-TAF12 interactions in the VDR hyper-sensitivity of osteoclast precursors in Paget’s disease
J Teramachi, Y Hiruma, S Ishizuka, H Ishizuka, JP Brown, L Michou, H Cao, DL Galson, MA Subler, H Zhou, DW Dempster, JJ Windle, GD Roodman, N Kurihara
Journal of Bone and Mineral Research 2013
Genetics of Bone Biology and Skeletal Disease
CS Kovacs
Genetics of Bone Biology and Skeletal Disease 2013
CXCL5 stimulation of RANK ligand expression in Paget’s disease of bone
K Sundaram, DS Rao, WL Ries, SV Reddy
Laboratory Investigation 2013
SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone: RANK Ligand Expression in Paget'S Disease
K Sundaram, J Senn, SV Reddy
Journal of Cellular Biochemistry 2013
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
MD Ruppe, SM de Beur
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2013
Vaccines
RW Sutter, OM Kew, SL Cochi, RB Aylward
Human vaccines 2013
Measles virus nucleocapsid protein, a key contributor to Paget’s disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1signaling
FM Wang, A Sarmasik, Y Hiruma, Q Sun, B Sammut, JJ Windle, GD Roodman, DL Galson
Bone 2012
The Joint Meeting of the 44th Annual Meeting of Japanese Society for Connective Tissue Research and the 59th Annual Meeting of the Japan Matrix Club, June 7-8, 2012, Tokyo, Japan
E Adachi, T Nishiyama, Y Tagawa, S Ohara
Connective Tissue Research 2012
Pathogenesis of Paget Disease of Bone
SH Ralston, R Layfield
Calcified Tissue International 2012
The transient appearance of zipper-like actin superstructures during the fusion of osteoclasts
J Takito, M Nakamura, M Yoda, T Tohmonda, S Uchikawa, K Horiuchi, Y Toyama, K Chiba
Journal of cell science 2012
Contributions of the Measles Virus Nucleocapsid Gene and the SQSTM1/p62P392L Mutation to Paget's Disease
N Kurihara, Y Hiruma, K Yamana, L Michou, C Rousseau, J Morissette, DL Galson, J Teramachi, H Zhou, DW Dempster, JJ Windle, JP Brown, GD Roodman
Cell Metabolism 2011
Emerging strategies and therapies for treatment of Paget's disease of bone
L Michou, JP Brown
Drug design, development and therapy 2011
Paget's Disease of Bone: Evidence for Complex Pathogenetic Interactions
PY Chung, WV Hul
Seminars in Arthritis and Rheumatism 2011
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick
Williams Textbook of Endocrinology 2011
Insights into the pathogenesis of Paget's disease: Osteoclasts in Paget's disease
GD Roodman
Annals of the New York Academy of Sciences 2010
Genetic aspects of the Paget’s disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application
F Alberto, M Francesca, M Laura, A Antonietta, BM Luisa
European Journal of Clinical Investigation 2010
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone
L Gennari, F Gianfrancesco, MD Stefano, D Rendina, D Merlotti, T Esposito, S Gallone, P Fusco, I Rainero, P Fenoglio, M Mancini, G Martini, S Bergui, GD Filippo, G Isaia, P Strazzullo, R Nuti, G Mossetti
Journal of Bone and Mineral Research 2010
Pagetʼs disease of bone: thereʼs more than the affected skeletal – a clinical review and suggestions for the clinical practice
A Falchetti, L Masi, ML Brandi
Current Opinion in Rheumatology 2010
Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management
JL Shaker
Therapeutic Advances in Musculoskeletal Diseases 2009
The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts
E Chamoux, J Couture, M Bisson, J Morissette, JP Brown, S Roux
Molecular Endocrinology 2009
FGF-2 Stimulation of RANK Ligand Expression in Paget’s Disease of Bone
K Sundaram, J Senn, S Yuvaraj, DS Rao, SV Reddy
Molecular Endocrinology 2009
Paget's disease of bone--becoming a rarity?
S Bastin, H Bird, G Gamble, T Cundy
Rheumatology 2009
Synthesis and Biological Activities of VDR Antagonists; 25-Modified 1α,25-Dihdyroxyvitamin D3-26,23-lactam (DLAM) Derivatives
K Nagasawa, Y Kato-Nakamura, S Ishizuka, H Saitoh, J Namekawa, K Takenouchi
HETEROCYCLES 2009
Paget’s disease of bone
B Matthews, T Cundy
Expert Review of Endocrinology & Metabolism 2009
Pharmacology and Therapeutics
BL Clarke, S Khosla
Pharmacology & Therapeutics 2009
Paget’s disease of bone: a review of epidemiology, pathophysiology and management
JL Shaker
Therapeutic Advances in Musculoskeletal Diseases 2009
The p62 P392L Mutation Linked to Paget’s Disease Induces Activation of Human Osteoclasts
E Chamoux, J Couture, M Bisson, J Morissette, JP Brown, S Roux
Molecular Endocrinology 2009
Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity
S Shanmugarajan, RF Youssef, P Pati, WL Ries, DS Rao, SV Reddy
Journal of Cellular Biochemistry 2008
The Osteoclast: Friend or Foe?
DV Novack, SL Teitelbaum
Annual Review of Pathology: Mechanisms of Disease 2008
Pathogenesis of Paget's disease of bone
SH Ralston
Bone 2008
1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells
S Ishizuka, N Kurihara, Y Hiruma, D Miura, J Namekawa, A Tamura, Y Kato-Nakamura, Y Nakano, K Takenouchi, Y Hashimoto, K Nagasawa, GD Roodman
The Journal of Steroid Biochemistry and Molecular Biology 2008
Benign fibro-osseous lesions of the craniofacial complex. A review
R Eversole, L Su, S ElMofty
Head and Neck Pathology 2008
Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget's disease of bone
A Merchant, M Smielewska, N Patel, JD Akunowicz, EA Saria, JD Delaney, RJ Leach, M Seton, MF Hansen
Journal of Bone and Mineral Research 2008
Dolor y aumento de diámetro de extremidad inferior izquierda
JG Dubois, VF Ladrón, JL Martínez, MU Echezarreta, I Insausti
Revista Clínica Española 2008
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
Mutation of the Sequestasome-1 Gene (p62) Increases Osteoclastogenesis but Does Not Induce Paget's Disease
Noriyoshi Kurihara, Yuko Hiruma, Hua Zhou, Mark A. Subler, David W. Dempster, Frederick R. Singer, Sakamuri V. Reddy, Helen E. Gruber, Jolene Windle, G. David Roodman
Journal of Clinical Investigation 2007
The molecular pathogenesis of Paget disease of bone
R Layfield
Expert Reviews in Molecular Medicine 2007
La enfermedad de Paget: la historia interminable
JP Montes
Reumatología Clínica 2007
Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function
H Rao, G Lu, H Kajiya, V Garcia-Palacios, N Kurihara, J Anderson, K Patrene, D Sheppard, HC Blair, JJ Windle, SJ Choi, GD Roodman
Journal of Bone and Mineral Research 2006
Experimental Models of Paget's Disease
N Kurihara, H Zhou, SV Reddy, VG Palacios, MA Subler, DW Dempster, JJ Windle, GD Roodman
Journal of Bone and Mineral Research 2006
Paget's Disease of Bone in the French Population: Novel SQSTM1 Mutations, Functional Analysis, and Genotype-Phenotype Correlations
C Collet, L Michou, M Audran, S Chasseigneaux, P Hilliquin, T Bardin, I Lemaire, F Cornélis, JM Launay, P Orcel, JL Laplanche
Journal of Bone and Mineral Research 2006
Sequestosome 1: Mutation Frequencies, Haplotypes, and Phenotypes in Familial Paget's Disease of Bone
J Morissette, N Laurin, JP Brown
Journal of Bone and Mineral Research 2006
Contribution of Genetic Factors to the Pathogenesis of Paget's Disease of Bone and Related Disorders
GJ Lucas, A Daroszewska, SH Ralston
Journal of Bone and Mineral Research 2006
Identification and Molecular Characterization of a Novel Splice-Site Mutation (G1205C) in the SQSTM1 Gene Causing Paget’s Disease of Bone in an Extended American Family
G Beyens, W Wuyts, E Cleiren, F Freitas, R Tiegs, W Hul
Calcified Tissue International 2006
Dynamics of Bone and Cartilage Metabolism
JE Mulder, CA Kulak, E Shane
Dynamics of Bone and Cartilage Metabolism 2006
Imaging of the Hip & Bony Pelvis
AM Davies, KJ Johnson, RW Whitehouse
2006
Practical Synthesis and Evaluation of the Biological Activities of 1α,25-dihydroxyvitamin D 3 Antagonists, 1α,25-dihydroxyvitamin D 3 -26,23-lactams. Designed on the Basis of the Helix 12-Folding Inhibition Hypothesis
Y Nakano, Y Kato, K Imai, E Ochiai, J Namekawa, S Ishizuka, K Takenouchi, A Tanatani, Y Hashimoto, K Nagasawa
Journal of Medicinal Chemistry 2006
Paget disease of bone
GD Roodman, JJ Windle
Journal of Clinical Investigation 2005
Characteristics and Familial Aggregation of Paget's Disease of Bone in Italy
D Merlotti, L Gennari, B Galli, G Martini, A Calabrò, VD Paola, E Ceccarelli, P Nardi, A Avanzati, R Nuti
Journal of Bone and Mineral Research 2005
Etiology of Paget's disease and osteoclast abnormalities
SV Reddy
Journal of Cellular Biochemistry 2004
Paget disease of bone
JR Tucci
Current Opinion in Endocrinology & Diabetes 2004
Synthesis of 1α,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1α,25-dihydroxyvitamin D3 antagonist
Y Kato, Y Nakano, H Sano, A Tanatani, H Kobayashi, R Shimazawa, H Koshino, Y Hashimoto, K Nagasawa
Bioorganic & Medicinal Chemistry Letters 2004
Synthesis and structure–activity relationships of TEI-9647 derivatives as Vitamin D3 antagonists
K Takenouchi, R Sogawa, K Manabe, H Saitoh, Q Gao, D Miura, S Ishizuka
The Journal of Steroid Biochemistry and Molecular Biology 2004
The cause of paget's disease?
T Cundy
BoneKEy-Osteovision 2004
Meeting report from the 26th annual meeting of the American society for bone and mineral research
R Bouillon, RF Klein, Y Jiang, M Petit, E Seeman, P Ducy, AA Reszka, D Bikle, E Schipani, GJ Strewler, M Seton
BoneKEy-Osteovision 2004
Paget disease of bone:
JR Tucci
Current Opinion in Endocrinology & Diabetes 2004
24,24-Dimethylvitamin D3-26,23-lactones and their 2α-functionalized analogues as highly potent VDR antagonists
N Saito, M Masuda, T Matsunaga, H Saito, M Anzai, K Takenouchi, D Miura, S Ishizuka, M Takimoto-Kamimura, A Kittaka
Tetrahedron 2004
Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells
S Ishizuka, N Kurihara, D Miura, K Takenouchi, J Cornish, T Cundy, SV Reddy, GD Roodman
The Journal of Steroid Biochemistry and Molecular Biology 2004
Paget's disease-a VDR coactivator disease?
N Kurihara, S Ishizuka, A Demulder, C Menaa, GD Roodman
The Journal of Steroid Biochemistry and Molecular Biology 2004
Paget?s Disease of Bone in New Zealand: Continued Decline in Disease Severity
HR Cundy, G Gamble, D Wattie, M Rutland, T Cundy
Calcified Tissue International 2004
La malattia ossea di Paget: diagnosi e terapia
P Filipponi
L'Endocrinologo 2004
Remarkable effect of 2α-modification on the VDR antagonistic activity of 1α-hydroxyvitamin D 3 -26,23-lactones
N Saito, T Matsunaga, T Fujishima, M Anzai, H Saito, K Takenouchi, D Miura, S Ishizuka, H Takayama, A Kittaka
Organic & Biomolecular Chemistry 2003
Design and synthesis of potent vitamin D receptor antagonists with A-ring modifications: remarkable effects of 2α-methyl introduction on antagonistic activity
T Fujishima, Y Kojima, I Azumaya, A Kittaka, H Takayama
Bioorganic & Medicinal Chemistry 2003
Analysis of Environmental Factors in Familial Versus Sporadic Paget's Disease of Bone-The New England Registry for Paget's Disease of Bone
M Seton, HK Choi, MF Hansen, RJ Sebaldt, C Cooper
Journal of Bone and Mineral Research 2003
Handbook of Cell Signaling
MF White
Handbook of Cell Signaling 2003
Sequence Analysis of Measles Virus Nucleocapsid Transcripts in Patients with Paget's Disease
WE Friedrichs, SV Reddy, JM Bruder, T Cundy, J Cornish, FR Singer, GD Roodman
Journal of Bone and Mineral Research 2002
Paget???s Disease of Bone in an Indian Patient
JS Nugent, KE O???Brien, M Harris, C Mohan
JCR: Journal of Clinical Rheumatology 2002
The Pro and Con of Measles Virus in Paget's Disease: Pro
WE Friedrichs, SV Reddy, FJ Singer, GD Roodman
Journal of Bone and Mineral Research 2002
Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand
JH Han, SJ Choi, N Kurihara, M Koide, Y Oba, GD Roodman
Blood 2001
Genomewide Search in Familial Paget Disease of Bone Shows Evidence of Genetic Heterogeneity with Candidate Loci on Chromosomes 2q36, 10p13, and 5q35
LJ Hocking, CA Herbert, RK Nicholls, F Williams, ST Bennett, T Cundy, GC Nicholson, W Wuyts, WV Hul, SH Ralston
The American Journal of Human Genetics 2001
Systemic therapy of myeloma xenografts by an attenuated measles virus
KW Peng, GJ Ahmann, L Pham, PR Greipp, R Cattaneo, SJ Russell
Blood 2001
RANKing the importance of measles virus in Paget’s disease
FP Ross
Journal of Clinical Investigation 2000
Osteoclast differentiation from circulating mononuclear precursors in Paget’s disease is hypersensitive to 1,25-dihydroxyvitamin D3 and RANKL
SD Neale, R Smith, JA Wass, NA Athanasou
Bone 2000
Therapeutic Approaches to Bone Diseases
GA Rodan
Science 2000
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
J E Fata, Y Y Kong, J Li, T Sasaki, J Irie-Sasaki, R A Moorehead, R Elliott, S Scully, E B Voura, D L Lacey, W J Boyle, R Khokha, J M Penninger
Cell 2000
Evasion of Host Defenses by Measles Virus: Wild-Type Measles Virus Infection Interferes with Induction of Alpha/Beta Interferon Production
D Naniche, A Yeh, D Eto, M Manchester, RM Friedman, MB Oldstone
Journal of virology 2000
Osteoporosis
DL Glaser, FS Kaplan
Spine 1997
Rheumatology
RA Asherson, R Cervera, DP D'Cruz, GR Hughes
Postgraduate medical journal 1991
Vitamin D
A Portale, Β Halloran, E Lonergan, R Morris
Vitamin D 1988
Paget's disease of bone
ES Siris, TP Jacobs, RE Canfield
Bulletin of the New York Academy of Medicine 1980

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
27 readers on Mendeley
See more details